Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations.

BMC Pulm Med · 2023 · PMC10688060 · PMID 38031067

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

an evident trendP = 0.051so close (0.05 < p ≤ 0.1)

Moreover, there was an evident trend that naïve CD4 T cells ( P = 0.051) and follicular helper T cells ( P = 0.050) were more abundant in NTRK3 MT NSCLC, while the infiltration of Tregs ( P = 0.009) was more enriched in NTRK3 WT NSCLC (Fig. 5 D).

also in 70 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.